Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

NCT06645210 | Not Yet Recruiting DMC

• 1 other identifier: M2024692
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.

Conditions

Allergic Bronchopulmonary Aspergillosis

Keywords

cohort study

Outcome Measures

Primary Outcomes (1)

• Clinical classification and treatment response criteria for ABPA

  1. Acute ABPA 2. Response 3. Remission 4. Treatment-dependent ABPA 5. Advanced ABPA

  1 year

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients who were diagnosed with ABPA

You may qualify if:

• Meeting the diagnosis of ABPA according to the ABPA diagnostic criteria specified by the ISHAM-ABPA working group in 2024

You may not qualify if:

• ABPA patients who are not first diagnosed in the center

Sponsors & Collaborators

• Peking University Third Hospital: lead
• First Affiliated Hospital of Guangxi Medical University: collaborator
• Guangzhou Institute of Respiratory Disease: collaborator
• Tongji Hospital: collaborator
• Nanfang Hospital, Southern Medical University: collaborator
• The First Affiliated Hospital with Nanjing Medical University: collaborator
• Qianfoshan Hospital: collaborator
• The First Affiliated Hospital of Shanxi Medical University: collaborator
• Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine: collaborator
• West China Hospital: collaborator
• Second Affiliated Hospital of Xi'an Jiaotong University: collaborator
• Second Affiliated Hospital, School of Medicine, Zhejiang University: collaborator
• Xiangya Hospital of Central South University: collaborator
• Peking Union Medical College Hospital: collaborator
• Ruijin Hospital: collaborator

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

MeSH Terms

Conditions

Aspergillosis, Allergic Bronchopulmonary

Condition Hierarchy (Ancestors)

Pulmonary Aspergillosis; Aspergillosis; Mycoses; Bacterial Infections and Mycoses; Infections; Lung Diseases, Fungal; Respiratory Tract Infections; Lung Diseases; Respiratory Tract Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof

Study Record Dates

• First Submitted: October 11, 2024
• First Posted: October 16, 2024
• Study Start: October 15, 2024
• Primary Completion: December 31, 2025
• Study Completion: January 31, 2026
• Last Updated: October 16, 2024

Record last verified: 2024-10

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)